Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-23

Clinical Trial Update: Benralizumab Initiated During Severe Asthma Attack [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring benralizumab initiation during a severe asthma attack.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benralizumab (benralizumab)

Snippet

Sponsor: Singapore General Hospital | Conditions: Asthma Attack, Asthma | Phase 2 | Status: UNKNOWN